Your SlideShare is downloading. ×
Presentationonlipid 100907041325-phpapp01
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Presentationonlipid 100907041325-phpapp01


Published on

Published in: Business, Technology
1 Like
  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 2. Why lipids are important- Lipids are important to the body because;- 1) Important constituent of the cell membranes. 2) Helps in the absorption of fat soluble vitamins. 3) Maintains membrane fluidity. 4) Acts as a thermal insulator and cellular metabolic regulator. 5) Hormone synthesis. 6) Organ padding. •
  • 3. Major lipids of physiological significance;- Fatty acids ;- basic units of fat composed of chains of carbon atoms with an acid group at one end and hydrogen atoms attached all along their length. Present as either esterified or unesterified form in fats and oils.
  • 4. Classification of fatty acids;- Fatty acidsSaturated FA Unsaturated FA
  • 5. Saturated fatty acids;-• Saturated fatty contains no double bonds (having no points of unsaturation). Saturated fats- considered as harmful. It increases total cholesterol level and TGs level. Hypercholestrolemic SFAs are-Myristic acid & Lauric acid.
  • 6. Unsaturated fatty acids;-Unsaturated fatty acid: a fatty acid with one or more points ofunsaturation. Unsaturated fats are found in foods from both plantand animal sources. Unsaturated fatty acids are further dividedinto monounsaturated fatty acids and polyunsaturated fatty acids.
  • 7. Divisions of unsaturated fatty acids;- Unsaturated Fatty acids MUFA PUFA Eicosanoids
  • 8. Monounsaturated fatty acids;- Monounsaturated fatty acid: a fatty acid containing one point of unsaturation, found mostly in vegetable oils such as olive, canola, and peanut. They are considered as beneficial for human health. MUFA Cis FA Trans FA
  • 9. Cis- unsaturated fatty acids;- In cis bonds, the two pieces of the carbon chain on either side of the double bond are either both “up” or both “down,” such that both are on the same side of the molecule. Significance – Decreases total cholesterol and TGs level. Increases HDL level.
  • 10. Trans unsaturated fatty acids;- Trans fatty acids are produced by hydrogenation process. Hydrogen atoms are on the opposite sides of the molecule. Eg.cis-oleic acid trans-elaidic acid PHYSIOLOGICAL EFFECTS OF TRANS FATTY ACIDS - SERUM LIPIDS -SYSTEMIC INFLAMMATION -ENDOTHELIAL-CELL FUNCTION
  • 11. Physiological effects of trans fatty acids continued… SERUM LIPIDS— >raises levels of low-density lipoprotein (LDL) cholesterol reduces levels of high-density lipoprotein (HDL) cholesterol >increases the ratio of total cholesterol to HDL cholesterol, a powerful predictor of the risk of CHD >increase the blood levels of triglycerides , of Lp(a) lipoprotein, and reduce the particle size of LDL cholesterol: further raise the risk of CHD. >trans fatty acids have markedly adverse effects on serum lipids
  • 12. Physiological effects of trans fatty acids continued… Systemic inflammation— inflammation: an independent risk factor for atherosclerosis, sudden death from cardiac causes, diabetes, and heart failure the inflammatory effects of trans fats may account in part for their effects on cardiovascular health For example, the difference in C-reactive protein levels ; 2.1 percent vs 0.9 percent intake: an increase in cardiovascular risk of approximately 30 percent.
  • 13. Physiological effects of trans fatty acids continued… ENDOTHELIAL-CELL FUNCTION-- increased levels of several markers of endothelial dysfunction: for eg;- soluble intercellular adhesion molecule, soluble vascular- cell adhesion molecule, and E-selectin
  • 14. Polyunsaturated fatty acids;- Polyunsaturated fatty acids (sometimes abbreviated PUFA) are those fatty acids where unsaturation occur more than two points, found in nuts and vegetable oils such as safflower, sunflower, and soybean, and in fatty fish. They possess protective role on human health.considered as beneficial for consumpmtion.
  • 15. PUFA continued;- Increase esterification process of cholesterol & prevents its absorption. By increasing the synthesis of eicosanoids. Acts as an anti platelet aggregating factor, so decreases the chances of clot formation. Decreases the synthesis of the precursor of VLDL AND TGs. Increases clearance of LDL cholesterol.
  • 16.  Omega-3-fatty acids-Benefits->Lower PGE2s level>Anti-inflammatory>Lower triglyceride andcholesterol levels>Benefits vision and>brain function>Decrease Skin>inflammation>Inhibit platelet adhesion>Increase insulinsensitivity
  • 17. Omega-6 fatty acids-Linoleic fatty acidArachidonic acidBenefits-Platelet aggregation,cardiovasculardiseases, andinflammation.Reduce the symptomsof eczema andpsoriasis.Clear up differenttypes of acne.
  • 18. Eicosanoids;- These compounds are derived from long chain polyenoic fatty acids (20-carbon). Examples of eicosanoids;- They have roles in: Inflammation Prostaglandins. Fever Prostacyclines, Regulation of blood pressure Blood viscosity Thromboxanes Male fertility Leukotrienes Female conception lipoxins Muscle cotraction Blood clotting Tissue growth Regulation of sleep/wake cycle Bronchocostriction Asthma.
  • 19. Triglycerides;-Structure Glycerol + 3 fatty acidsFunctions Energy source--9 kcals per gram Form of stored energy in adipose tissue. Insulation and protection Carrier of fat-soluble vitamins Sensory properties in food
  • 20. Phospholipids;- main lipid constituent of cell membrane.Structure Glycerol + 2 fatty acids + phosphate group also considered as derivative of ‘phosphatidic acid’.Functions Main lipid constituent of cell membranes Lipid transport as part of lipoproteins Emulsifiers Cell signalling process. phospholipids Phos.choline phos.inositol cardiolipin lysophospholipid plasmalogens sphingomy.
  • 21. Sterols;-Steroids are the compounds containscyclic steroid nucleus namely cyclopentanophenanthrene ring.Cholesterol-best known steroid because of itsassociation with atherosclerosis andheart diseases.Contains same steroid nucleus.Exclusively present in animals. Functions;---Bile acids– Sex hormones– Adrenal hormones– Vitamin D--Cardiac glycosides
  • 22. Glycolipids;- --widely distributed in the body Fatty acids + sphingosine +carbohydrate Also k/a glycosphingolipids. Present in cell membrane and nervous tissues. It contributes to cell surface carbohydrate Other glycolipids are;- Cerebrosides- simplest form of glycolipids.contains ceramides. eg. Galactosylcerebrosides glucosylcerebrosides Gangliosides – predominantly found in ganglions.Complex glycolipids
  • 23. Lipoproteins;-Lipoproteins are thmacromolecular complex oflipids and proteins.Transportation of lipids in theblood.Structure of lipoproteins;-Hydrophobic lipids (TG, CE) incore;Hydrophilic lipids (UC, PL) onsurface
  • 24. Classes of lipoproteins;- Chylomicrons, LDL HDL VLDL,> 30 nm 20–22 nm 9–15 nmD<1.006 g/ml D=1.019-1.063g/ml D=1.063-1.21 g/ml Doi H et al. Circulation 2000;102:670-676; Colome C et al. Atherosclerosis 2000; 149:295-302; Cockerill GW et al. Arterioscler Thromb Vasc Biol 1995;15:1987-1994
  • 25.  Apolipoproteins— Apo AI (liver, small intestine)  Structural; activator of lecithin:cholesterol acyltransferase (LCAT) Apo AII (liver)  Structural; inhibitor of hepatic lipase; component of ligand for HDL binding Apo A-IV (small intestine)  Activator of LCAT; modulator of lipoprotein lipase (LPL) Apo A-V (liver)  Direct functional role is unknown; regulates TG levels.
  • 26.  Apoprotein continued… Apo B-100 (liver)  Structural; synthesis of VLDL; ligand for LDL-receptor Apo B-48 (small intestine)  Structural; synthesis of chylomicrons; derived from apo B- 100 mRNA following specific mRNA editing Apo E (liver, macrophages, brain)  Ligand for apoE receptor; mobilization of cellular cholesterol
  • 27. Apoprotein continued… Apo C-I (liver)  Activator of LCAT, inhibitor of hepatic TGRL uptake Apo C-II (liver)  Activator of LPL, inhibitor of hepatic TGRL uptake Apo C-III (liver)  Inhibitor of LPL, inhibitor of hepatic TGRL uptake
  • 28. Chylomicrons;- TG rich. Synthesized in intestine. Transports endogenous TGs. Hydrophobic Core Triglyceride (93%) Cholesteryl Esters (1%)
  • 29. VLDL;- rich in CE and TGs- Surface Monolayer Phospholipids (12%) Free Cholesterol (14%) Protein (4%) Hydrophobic Core Triglyceride (65%) Cholesteryl Esters (8%)
  • 30. LDL;- cholesterol rich. Surface Monolayer Phospholipids (25%) Free Cholesterol (15%) Protein (22%) Synthesized from VLDL in blood circulation. Transports cholesterol from liver and delivers to other tissues.
  • 31. High density lipoprotein- Surface Monolayer Phospholipids (25%) Free Cholesterol (7%) Protein (45%) Promotes re- esterification process of cholesterol.
  • 32. HDL Subpopulations Particle Shape Apolipoprotein Composition Discoidal Spherical A-I HDL A-I/A-II A-II HDL HDL Particle Size Lipid Composition TG, CE, and PL HDL2b HDL2a HDL3a HDL3b HDL3cRye et al. Atherosclerosis 1999;145:227-238.
  • 33.  The Effects of Various Types of Fat on Blood Lipid Levels • Saturated Fat – Increases total cholesterol – Increases LDL-cholesterol • Polyunsaturated Fat – Decreases total cholesterol – Decreases LDL-cholesterol – Decreases HDL-cholesterol • Monounsaturated Fat – Decreases total cholesterol – Decreases LDL-cholesterol – Increases HDL-cholesterol
  • 34.  Omega-3 Fat – Decreases total cholesterol – Decreases LDL-cholesterol – Increases HDL-cholesterol – Decreases serum triglycerides • Trans Fat – Increases total cholesterol – Increases LDL-cholesterol
  • 35. Role of lipids in health and diseases – omega-3 FAs.Docosahexanoic acid andbrain development-It is becoming increasingly evident that long-chain PUFAfrom the (n-3) family appear to be neuroprotective andthat long-chain PUFA from the (n-6family) may also haveunique properties in affecting neurobiology.•It is found in very high concentrations in the cellmembranes of the retina and cerebral cortex.•Whelan et al,(2008) focused on docosahexaenoicacid (DHA),4 a PUFA that is preferentiallydeposited in brain phospholipids and has beenlinked to dementia, Parkinson disease, Alzheimerdisease (AD),cognitive function, mental stability,suicide, depression, bipolar disorders, impulsivity,aggression, etc. (3–10). The content of DHA in thebrain is 12–15%, 10- to 20-fold higher than anyother (n-3) PUFA.
  • 36. Arachidonic acid and the brain--One of the most important changes in this field is the link between arachidonic acid(AA) content and brain function. The level of AA in the brain is comparable to thatof DHA. At 8–11% of the fatty acid phospholipids, it is severalfold higherthan any other (n-6) PUFA (by comparison, linoleic acid content is ;1%).Connell et al,(2007) demonstrated that dietary AA appears to influence plasticityand preserve hippocampal membrane fluidity and may provide some protection tooxidative stress via the activation of peroxisomal proliferatoractivatedreceptor-g (17). Furthermore, it has been shown that AA, as well as DHA, activatessyntaxin-3, a critical factor in the growth and regeneration of neurons.
  • 37. Prevention of cancer;-Marine-derived fatty acids have been found to inhibitproliferation and promote apoptosis in breast, prostate, and coloncancer cell lines cultured outside the bodyStudies in animal models of cancer also indicate that increasedintake of EPA and DHA decreases the occurrence andprogression of mammary, prostate, and intestinal tumors
  • 38. Lipids related disorders;- lipid disordersCommon disorders Uncommon disordersHypercholetrolemia Metabolic disorders of cerebrosides.Hypertriglyceridemia Lipidoses / lipid storage diseasesHyperlipoproteinemia Multiple sclerosis.ketosis Infant respiratory distress syndromeCVD Xanthomatosis.Fatty liver Retinitis pigmentosa.Obesity Phrynoderma / Toad skin.cancer Disorders of EFAs deficiency. Zwellweger’s disease.
  • 39.  ATHEROSCLEROSIS: As LDL particles penetrate the walls of the arteries, they become oxidized-LDL and next are scavenged by the body’s white blood cells. • These foam cells are then deposited into the lining of the artery wall. • This process, known as atherosclerosis, causes plaque deposits to enlarge, artery walls to lose elasticity, and the passage through the artery to narrow.
  • 40. Diagrammatic representation of the disease (atherosclerosis)-
  • 41. Metabolic disorders of cerebrosidesdiseases Enzyme Lipid symptoms deficiency accumulatingTay –sachs hexosamini gangliosides Mentalretardation,blindness,muscudisease dase lar weakness.Fabry;’s A- galactosylceramide Skin rashes,kidney failuredisease galactosidase.Krabbe’s B- galactosylceramid Mental retardation,complete lossdisease galactosidas e of myelin sheath. eGaucher’s B- glucosylceramide Enlarged liver and spleen, eroisondisease glucosidase of long bones ,mental retardationNiemann- sphingomye sphingomyelin Enlarged liver and spleenpick disease linaseFarber’s ceramidase ceramide Dermatitis,skeletaldisease deformation,hoarseness.Ref- Harper’s biochemistry
  • 42. Lipoprotein disorders;- Hyperlipoproteinemias-Hy. Metabolic defect Increased plasma Risk of athersclerosisLipo.types lipid mostl Deficiency of chylomicrons increase lipoproteinlipasella Deficiency of cholesterol Very high LDLreceptorsllb Overproduction of TGs and cholesterol high apo-blll Abnormality in apo -e TGs and cholesterol highlv Overproduction of TGs May/may not increase TGsv --do-- Chylomicron and --do-- VLDLRef- Harper’s biochemistry
  • 43. Infant repiratory distress syndrome-Caused due to the deficiency of the lung surfactant dipalmitoyl lecithin.It prevents collapsing of the alveoli and also decreases the surface tension .Deficiency is common in young infants.Xanthomatosis;-Deposition of yellow-orange colours lipids occurs in the liver ,spleen and flatbones.Usually related with severe hypercholesterolemia and hyperlipidemia.Phrynoderma or Toad skin;-Caused due to the deficiency of essential fatty acids.Horny eruptions occurs on posterior and lateral limbs.poor wound healing.Multiple sclerosis;-It is a demyelinating condition. loss of both phospholipids and sphingolipidsoccurs from white matter. Neurodegeneration is common.
  • 44. Defects in the metabolism of essential fatty acids -Cystic fibrosis,Acrodermatitis enterohepatica,Hepato renal syndrome, Crohn’sdisease,Cirrhosis, Alcoholism, Reyes syndrome etc.Zwellweger’s disease;-Rare disorder.occurs due to the accumulation of long chain polyenoic fatty acids in the brain.Causes loss of functions and neural degeneration .Dicarboxylic aciduria-It is characterized by the excretion of C6-C10 dicarboxylic acid due to the lack ofmitochondrial acyl coA dehydrogenase enzyme.
  • 45. Common Atherogenic dyslipidemias) 􀂃 polygenic inheritance– dietary component– secondarily enhanced byinsulin resistance (seefurther why) 􀂃 prognosis of combinedhyperlipidemia is worsethan that ofhypercholesterolemia 􀂃 main features– impaired clearance of TAGby LPL (􀂃 insulin) fromchylomicrons → increasedTAG and increased deliveryof TAG for liver– increased production ofVLDL by liver (􀂃 insulin)from TAG, FFA from adiposetissue (􀂃 insulin) andglucose (􀂃 insulin)– therefore increasedconversion of VLDL to LDL– low HDL
  • 46. Fatty liver;-When lipids accumulates excessively in liver, then it causes fatty liver.Dropletes of TGs are found in the entire hepatic cytoplasm,this causes impairment in liver function.Fatty liver may occur due to two main reason-1) Increased synthesis of TGs.2) Impairment in lipoprotein synthesis.Fatty liver is associated with the fibrotic changes and cirrhosis.
  • 47. Tangier Disease>Autosomal codominant disorder due to mutations in both alleles of ABC1 gene • Extremely marked reduction in HDL-C and apoA-I • Markedly accelerated catabolism of apoA-I and>apoA-II • Cholesterol accumulation: − Enlarged orange tonsils − Hepatosplenomegaly − Peripheral neuropathy
  • 48. References--1) Connell E, Darios F, Broersen K, Gatsby N, Peak-Chew SY, Rickman C,Davletov B. Mechanism of arachidonic acid action on syntaxin- Munc18.EMBO Rep. 2007;8:414–92) Granner,K. and Robert,K.(2006).Harper’s illustrated biochemistry .27thedition.Tata McGraw Hills publication.3)Satyanarayan,U. (2006).Biochemistry.3rd edition. Books and Allied (P)Ltd.4) Whelan ,J.(2008).(n-6) and (n-3) Polyunsaturated Fatty Acids and theAging Brain: Food for Thought. Abstract J. Nutr. 138: 2521–2522.